[Antinephritic effect of MD-805 [(2R, 4R) -4-methyl-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl) -L-arginyl] -2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GMB nephritis in rats].
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives; D001485:Basement Membrane / Q000276:immunology; D001806:Blood Urea Nitrogen; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000473:pathology; D006493:Heparin / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000276:immunology; D008297:Male; D010875:Pipecolic Acids / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; D013917:Thrombin; D014568:Urokinase-Type Plasminogen Activator; C031942:argatroban